| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.05 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |